Endo Starts Fresh As Financial Restructuring Plan Gets Confirmed
The Firm Filed For Bankruptcy Following $8bn Debt And US Opioid Claims In August 2022
Endo says it is on a path of “sustained growth” as the company gets ready to emerge under a new name later next month.
